Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ABIVAX-22387984/news/Abivax-erhalt-FDA-Genehmigung-fur-den-Start-klinischer-Studien-mit-ABX464-in-den-USA-zur-Behandlun-29864615/?utm_source=whatsapp&utm_medium=social&utm_campaign=share